Safety and effectiveness of bubble continuous positive airway pressure as respiratory support for bronchiolitis in a pediatric ward.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 24 11 2021
accepted: 05 09 2022
revised: 20 08 2022
pubmed: 22 9 2022
medline: 15 11 2022
entrez: 21 9 2022
Statut: ppublish

Résumé

The results of several clinical trials suggest that continuous positive airway pressure (CPAP) for acute bronchiolitis can be more effective than high-flow nasal cannula (HFNC). The use of HFNC involved a minimum reduction (5%) in admissions to the pediatric intensive care unit (PICU) in our hospital. Our main aim was to evaluate its safety and effectiveness as respiratory support for patients with bronchiolitis in a pediatric general ward. A secondary goal was to compare the admissions to PICU and the invasive mechanical ventilation (IMV) rate of patients treated with HFNC and those treated with HFNC/b-CPAP during the 2018-2019 and 2019-2020 epidemic seasons, respectively. Two prospective single-centre observational studies were performed. For the main aim, a cohort study (CS1) was carried out from 1st of November 2019 to 15th of January 2020. Inclusion criteria were children aged up to 3 months with bronchiolitis treated with b-CPAP support when HFNC failed. Epidemiological and clinical parameters were collected before and 60 min after the onset of CPAP and compared between the responder (R) and non-responders (NR) groups. NR was the group that required PICU admission. One hundred fifty-eight patients were admitted to the ward with bronchiolitis and HFNC. Fifty-seven out of one hundred fifty-eight required b-CPAP. No adverse events were observed. Thirty-two out of fifty-seven remained in the general ward (R-group), and 25/57 were admitted to PICU (NR-group). There were statistically significant differences in respiratory rate (RR) and heart rate (HR) between both groups before and after the initiation of b-CPAP, but the multivariable models showed that the main differences were observed after 60 min of therapy (lower HR, RR, BROSJOD score and FiO2 in the R-group). For the secondary aim, another cohort study (CS2) was performed comparing data from a pre-b-CPAP bronchiolitis season (1st of November 2018 to 15th January 2019) and the b-CPAP season (2019-2020). Inclusion criteria in pre-b-CPAP season were children aged up to 3 months admitted to the same general ward with moderate-severe bronchiolitis and with HFNC support. Admissions to PICU during the CPAP season were significantly reduced, without entailing an increase in the rate of IMV. The implementation of b-CPAP for patients with bronchiolitis in a pediatric ward, in whom HFNC fails, is safe and effective and results in a reduction in PICU admissions. • Bronchiolitis is one of the most frequent respiratory infections in children and one of the leading causes of hospitalization in infants. • Several studies suggest that the use of continuous positive airway pressure (CPAP) for acute bronchiolitis can be more effective than the high flow nasal cannula (HFNC). CPAP is a non-invasive ventilation (NIV) therapy used in patients admitted to pediatric intensive care unit (PICU) with progressive moderate-severe bronchiolitis. There is little experience in the literature on the use of continuous positive airway pressure (CPAP) for acute bronchiolitis in a general ward. • CPAP could be safely and effectively used as respiratory support in young infants with moderate-severe bronchiolitis in a general ward and it reduced the rate of patients who required PICU admission. • Patients' heart and respiratory rate and their FiO2 needs in the first 60 minutes may help to decide whether or not to continue the CPAP therapy in a general ward.

Identifiants

pubmed: 36129536
doi: 10.1007/s00431-022-04616-3
pii: 10.1007/s00431-022-04616-3
pmc: PMC9649485
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

4039-4047

Informations de copyright

© 2022. The Author(s).

Références

Sanchez-Luna M, Elola FJ, Fernandez-Perez C, Bernal JL, Lopez-Pineda A (2016) Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004–2012. Curr Med Res Opin 32(4):693–698. https://doi.org/10.1185/03007995.2015.1136606
doi: 10.1185/03007995.2015.1136606 pubmed: 26709735
Hall CB, Simőes EA, Anderson LJ (2013) Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol 372:39–57. https://doi.org/10.1007/978-3-642-38919-1_2
doi: 10.1007/978-3-642-38919-1_2 pubmed: 24362683
Øymar K, Skjerven HO, Mikalsen IB (2014) Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med 3(22):23. https://doi.org/10.1186/1757-7241-22-23
doi: 10.1186/1757-7241-22-23
Zorc JJ, Hall CB (2010) Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 125(2):342–349. https://doi.org/10.1542/peds.2009-2092
doi: 10.1542/peds.2009-2092 pubmed: 20100768
Milési C, Baleine J, Matecki S, Durand S, Combes C, Novais AR, Cambonie G (2013) Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study Intensive Care Med 39(6):1088–1094. https://doi.org/10.1007/s00134-013-2879-y
doi: 10.1007/s00134-013-2879-y pubmed: 23494016
Milési C, Boubal M, Jacquot A, Baleine J, Durand S, Odena MP, Cambonie G (2014) High-flow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care 30(4):29. https://doi.org/10.1186/s13613-014-0029-5 (PMID:25593745;PMCID:PMC4273693)
doi: 10.1186/s13613-014-0029-5
Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J, Furyk J, Fraser JF, Jones M, Whitty JA et al (2018) A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. N Engl J Med 378(12):1121–1131. https://doi.org/10.1056/NEJMoa1714855 (PMID: 29562151)
doi: 10.1056/NEJMoa1714855 pubmed: 29562151
Kepreotes E, Whitehead B, Attia J, Oldmeadow C, Collison A, Searles A, Goddard B, Hilton J, Lee M, Mattes J (2017) High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial. Lancet 389(10072):930–939. https://doi.org/10.1016/S0140-6736(17)30061-2 (Epub 2017 Feb 2 PMID: 28161016)
doi: 10.1016/S0140-6736(17)30061-2 pubmed: 28161016
Dafydd C, Saunders BJ, Kotecha SJ, Edwards MO (2021) Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis. BMJ Open Respir Res 8(1):e000844. https://doi.org/10.1136/bmjresp-2020-000844 (PMID:34326153;PMCID:PMC8323377)
doi: 10.1136/bmjresp-2020-000844 pubmed: 34326153 pmcid: 8323377
Turnham H, Agbeko RS, Furness J, Pappachan J, Sutcliffe AG, Ramnarayan P (2017) Non-invasive respiratory support for infants with bronchiolitis: a national survey of practice. BMC Pediatr 17:20
doi: 10.1186/s12887-017-0785-0 pubmed: 28095826 pmcid: 5240267
Goh C, Kirby L, Schell D, Egan JR (2017) Humidified high-flow nasal cannula oxygen in bronchiolitis reduces need for invasive ventilation but not intensive care admission. J Paediatr Child Health 53:897–902
doi: 10.1111/jpc.13564 pubmed: 28544665
Toni F, Cambra Lasaosa FJ, Conti G, Escuredo L, Benito S, Gelabert G, Pons-Òdena M (2019) Comparison in the management of respiratory failure due to bronchiolitis in a pediatric ICU between 2010 and 2016. Respir Care 64(10):1270–1278. https://doi.org/10.4187/respcare.06608 (Epub 2019 Jun 4 PMID: 31164482)
doi: 10.4187/respcare.06608 pubmed: 31164482
Milési C, Essouri S, Pouyau R, Liet JM, Afanetti M, Portefaix A, Baleine J, Durand S, Combes C, Douillard A, et al (2017) Groupe francophone de réanimation et d’Urgences pédiatriques (GFRUP). High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: a multicenter randomized controlled trial (TRAMONTANE study). Intensive Care Med 43:209–216.  https://doi.org/10.1007/s00134-016-4617-8
Jat KR, Mathew JL (2019) Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. Cochrane Database Syst Rev 1 Art. No.: CD010473.  https://doi.org/10.1002/14651858.CD010473.pub3
Habra B, Janahi IA, Dauleh H, Chandra P, Veten A (2020) A comparison between high-flow nasal cannula and noninvasive ventilation in the management of infants and young children with acute bronchiolitis in the PICU. Pediatr Pulmonol 55(2):455–461. https://doi.org/10.1002/ppul.24553 (Epub 2020 Jan 10 PMID: 31922360)
doi: 10.1002/ppul.24553 pubmed: 31922360
Beasley JM, Jones SE (1981) Continuous positive airway pressure in bronchiolitis. Br Med J (Clin Res Ed) 283:1506–1508
doi: 10.1136/bmj.283.6305.1506
Cambonie G, Milési C, Jaber S, Amsallem F, Barbotte E, Picaud JC, Matecki S (2008) Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe acute viral bronchiolitis. Intensive Care Med 34(10):1865–1872
doi: 10.1007/s00134-008-1201-x pubmed: 18607564
Larrar S, Essouri S, Durand P, Chevret L, Haas V, Chabernaud JL, Leyronnas D, Devictor D (2006) Effects of nasal continuous positive airway pressure ventilation in infants with severe acute bronchiolitis. Arch Pediatr 13:1397–1403
doi: 10.1016/j.arcped.2006.07.005 pubmed: 16959476
Øymar K, Bårdsen K (2014) Continuous positive airway pressure for bronchiolitis in a general paediatric ward; a feasibility study. BMC Pediatr 14:122
doi: 10.1186/1471-2431-14-122 pubmed: 24886569 pmcid: 4020573
Paredes E, Bueno M, Salomón Moreno B, Rupérez Lucas M, de la Morena MR (2019) Non-invasive ventilation in acute bronchiolitis on the ward. A viable option An Pediatr (Barc) 90(2):119–121. https://doi.org/10.1016/j.anpede.2018.04.007
doi: 10.1016/j.anpede.2018.04.007
Balaguer M, Alejandre C, Vila D, Esteban E, Carrasco JL, Cambra FJ, Jordan I (2017) Bronchiolitis Score of Sant Joan de Déu: BROSJOD Score, validation and usefulness. Pediatr Pulmonol 52(4):533–539. https://doi.org/10.1002/ppul.23546
doi: 10.1002/ppul.23546 pubmed: 28328090
Essouri S, Durand P, Chevret L, Balu L, Devictor D, Fauroux B, Tissières P (2011) Optimal level of nasal continuous positive airway pressure in severe viral bronchiolitis. Intensive Care Med 37(12):2002–2007
doi: 10.1007/s00134-011-2372-4 pubmed: 21993811
Gan WQ, Buxton JA, Scheuermeyer FX, Palis H, Zhao B, Desai R, Janjua NZ, Slaunwhite AK (2021) Risk of cardiovascular diseases in relation to substance use disorders. Drug Alcohol Depend 229:109132.  https://doi.org/10.1016/j.drugalcdep.2021.109132  (PMID: 34768052)
Holmberg M, Ghorbani P, Gilg S, Del Chiaro M, Arnelo U, Löhr JM, Sparrelid E (2021) Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma. Pancreatology 21(7):1371–1377. https://doi.org/10.1016/j.pan.2021.07.009 (Epub 2021 Aug 12 PMID: 34426077)
doi: 10.1016/j.pan.2021.07.009 pubmed: 34426077
Borckink I, Essouri S, Laurent M, Albers MJ, Burgerhof JG, Tissières P, Kneyber MC (2014) Infants with severe respiratory syncytial virus needed less ventilator time with nasal continuous airways pressure then invasive mechanical ventilation. Acta Paediatr 103(1):81–85. https://doi.org/10.1111/apa.12428 (Epub 2013 Nov 11 PMID: 24117695)
doi: 10.1111/apa.12428 pubmed: 24117695
Lazner MR, Basu AP, Klonin H (2012) Non-invasive ventilation for severe bronchiolitis: analysis and evidence. Pediatr Pulmonol 47:909–916
doi: 10.1002/ppul.22513 pubmed: 22328335
Essouri S, Laurent M, Chevret L, Durand P, Ecochard E, Gajdos V, Devictor D, Tissières P (2014) Improved clinical and economic outcomes in severe bronchiolitis with pre-emptive nCPAP ventilatory strategy. Intensive Care Med 40(01):84–91
doi: 10.1007/s00134-013-3129-z pubmed: 24158409
Service specifications (2018) Paediatric high dependency care. National Health System. England.  https://www.england.nhs.uk/wp-content/uploads/2018/08/Paediatric-high-dependency-care.pdf Accessed 14 Nov 2021
Machen HE, Mwanza ZV, Brown JK, Kawaza KM, Newberry L, Richards-Kortum RR, Oden ZM, Molyneux EM (2015) Outcomes of patients with respiratory distress treated with bubble CPAP on a pediatric ward in Malawi. J Trop Pediatr 61(6):421–427. https://doi.org/10.1093/tropej/fmv052
doi: 10.1093/tropej/fmv052 pubmed: 26361989
Walk J, Dinga P, Banda C, Msiska T, Chitsamba E, Chiwayula N, Lufesi N, Mlotha-Mitole R, Costello A, Phiri A et al (2016) Non-invasive ventilation with bubble CPAP is feasible and improves respiratory physiology in hospitalised Malawian children with acute respiratory failure. Paediatr Int Child Health 36(1):28–33. https://doi.org/10.1179/2046905514Y.0000000166
doi: 10.1179/2046905514Y.0000000166 pubmed: 25434361
Cesar RG, Bispo BRP, Felix PHCA, Modolo MCC, Souza AAF, Horigoshi NK, Rotta AT (2020) High-flow nasal cannula versus continuous positive airway pressure in critical bronchiolitis: a randomized controlled pilot. J Pediatr Intensive Care 9(4):248–255. https://doi.org/10.1055/s-0040-1709656
doi: 10.1055/s-0040-1709656 pubmed: 33133739 pmcid: 7588294
Jaimovich DG (2004) Committee on hospital care and section on critical care. AAP. Admission and discharge guidelines for the pediatric patient requiring intermediate care. Pediatrics 113(5):1430–3.  https://doi.org/10.1542/peds.113.5.1430
Lavilledieu D, Abassi H, Mercier G, Guiraud M, Chaffaut GD, Milesi C, Cambonie G, Gavotto A, Jeziorski E, Amedro P (2020) Implementation of an organizational infrastructure paediatric plan adapted to bronchiolitis epidemics. J Infect Public Health 13(2):167–172. https://doi.org/10.1016/j.jiph.2019.07.007
doi: 10.1016/j.jiph.2019.07.007 pubmed: 31378693
Clayton JA, McKee B, Slain KN, Rotta AT, Shein SL (2019) Outcomes of children with bronchiolitis treated with high-flow nasal cannula or noninvasive positive pressure ventilation. Pediatr Crit Care Med 20(2):128–135. https://doi.org/10.1097/PCC.0000000000001798
doi: 10.1097/PCC.0000000000001798 pubmed: 30720646

Auteurs

Marta Agüera (M)

Paediatrics Department, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain.

Maria Melé-Casas (M)

Paediatrics Department, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain.

Maria Mercedes Molina (MM)

Nurse of Paediatrics, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain.

Martí Pons-Odena (M)

Immunological and Respiratory Disorders, Paediatric Critical Care Unit Research Group, Institut de Recerca Sant Joan de Déu, Santa Rosa, no. 39-57, 08950, Esplugues de Llobregat, Spain.
Intensive Care Unit Department, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain.

Mariona F de-Sevilla (MF)

Paediatrics Department, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain.
Paediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Déu, Santa Rosa, no. 39-57, 08950, Esplugues de Llobregat, Spain.
Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, no. 3-5, pabellón 11, planta 0, 28029, Madrid, Spain.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Casanova, no. 143, 08036, Barcelona, Spain.

Juan-José García-García (JJ)

Paediatrics Department, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain.
Paediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Déu, Santa Rosa, no. 39-57, 08950, Esplugues de Llobregat, Spain.
Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, no. 3-5, pabellón 11, planta 0, 28029, Madrid, Spain.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Casanova, no. 143, 08036, Barcelona, Spain.

Cristian Launes (C)

Paediatrics Department, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain. cristian.launes@sjd.es.
Paediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Déu, Santa Rosa, no. 39-57, 08950, Esplugues de Llobregat, Spain. cristian.launes@sjd.es.
Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, no. 3-5, pabellón 11, planta 0, 28029, Madrid, Spain. cristian.launes@sjd.es.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Casanova, no. 143, 08036, Barcelona, Spain. cristian.launes@sjd.es.

Laura Monfort (L)

Paediatrics Department, Hospital Sant Joan de Déu, P. Sant Joan de Déu, no. 2, 08950, Esplugues de Llobregat, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH